We are pleased to announce the establishment of the Clinical Trials Department within the Healthcare Poland Foundation and the appointment of Klaudiusz Gajewski as Director of the Department.
Klaudiusz Gajewski has been appointed Director of the Clinical Trials Department at Healthcare Poland
Klaudiusz Gajewski brings to HCPL over 20 years’ experience in the pharmaceutical industry and a unique combination of skills:
✅ Expert knowledge of the clinical trials market – currently, as Commercial Director EU at CTIN (clinicaltrials.eu), he is coordinating the launch of a clinical trials search platform for the European market.
✅ Extensive experience in B2B strategy – previously at Merck Serono, Berlin Chemie Menarini, Movianto/Owens & Minor, and medAspis, amongst others.
✅ Ekspert sądowy w prawie farmaceutycznym – długoletni biegły sądowy specjalizujący się w dystrybucji produktów leczniczych.
✅ Relevant qualifications – Master’s degree in Pharmacy, MBA in Healthcare Management (University of Illinois / University of Minnesota / Lublin University of Technology).
✅ Co-author of the regulations – a long-standing contributor to the development of Polish pharmaceutical law and a former member of the Pharmaceutical Committee at the Business Centre Club.
The Role of the Clinical Trials Department
The HCPL Clinical Trials Department will focus on:
➜ supporting healthcare providers in accessing innovative treatments through clinical trials;
➜ building bridges between research sponsors, research centres and Polish hospitals;
➜ education and training on EU regulations governing clinical trials;
➜ integrating HCPL’s expertise in certification, auditing and compliance with the clinical trials ecosystem.
🎯 Clinical trials are one of the cornerstones of access to innovative treatments – an area that Healthcare Poland is consistently developing as part of its mission to improve the quality and accessibility of healthcare in Poland.
